Oblique Therapeutics

Fighting metastatic cancer

  • CEO: Owe Orwar
  • First investment year: 2015
  • Fund: West Sweden
  • Business sector: Life Science
Oblique Therapeutics

Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.